Time-series metabolomics insights into the progressive characteristics of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver fibrosis in mice

Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses

(2020) Guo-Feng Wang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Time Series Characteristics of Serum Branched-Chain Amino Acids for Early Diagnosis of Chronic Heart Failure

(2019) Ruiting Li et al.   JOURNAL OF PROTEOME RESEARCH

Protective effect of cultured bear bile powder against dimethylnitrosamine-induced hepatic fibrosis in rats

(2019) Min Zheng et al.   BIOMEDICINE & PHARMACOTHERAPY

Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice

(2019) Wen-Kai Li et al.   PHYTOMEDICINE

Metabolomic analysis of cholestatic liver damage in mice

(2018) Rui Yang et al.   FOOD AND CHEMICAL TOXICOLOGY

Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features

(2018) Carolina Palmela et al.   Gut and Liver

Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis

(2018) Jesus M Banales et al.   HEPATOLOGY

Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats

(2017) Jianlin He et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

(2017) Wei Jia et al.   Nature Reviews Gastroenterology & Hepatology

Chicken bile powder protects against α-naphthylisothiocyanate-induced cholestatic liver injury in mice

(2017) Yi-Fei Li et al.   Oncotarget

Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model

(2017) Kai Takegoshi et al.   Oncotarget

Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach

(2017) Hong Chang et al.   Scientific Reports

Dietary Linoleic Acid Lowering Reduces Lipopolysaccharide-Induced Increase in Brain Arachidonic Acid Metabolism

(2016) Ameer Y. Taha et al.   MOLECULAR NEUROBIOLOGY

Metabolomics: beyond biomarkers and towards mechanisms

(2016) Caroline H. Johnson et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Time-resolved metabolomics analysis of individual differences during the early stage of lipopolysaccharide-treated rats

(2016) Die Dai et al.   Scientific Reports

Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists

(2015) Palak J. Trivedi et al.   HEPATOLOGY

Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis inLdlr−/−mice by targeting the TGFβ-Smad3 pathway

(2015) Kelli A. Lytle et al.   JOURNAL OF LIPID RESEARCH

Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach?

(2015) Elvira Verduci et al.   Journal of Translational Medicine

Discovery of safety biomarkers for realgar in rat urine using UFLC-IT-TOF/MS and 1H NMR based metabolomics

(2013) Yin Huang et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats

(2011) Wen-Ying Chen et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY